+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Gastrointestinal Stromal Tumors Therapeutics Market 2024-2028

  • PDF Icon

    Report

  • 165 Pages
  • December 2023
  • Region: Global
  • TechNavio
  • ID: 5671364
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The gastrointestinal stromal tumors therapeutics market is forecasted to grow by USD 1.02 bn during 2023-2028, accelerating at a CAGR of 6.01% during the forecast period. The report on the gastrointestinal stromal tumors therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the growing geriatric population, growing adoption of gist therapeutics, and increasing awareness campaigns about gist.

The gastrointestinal stromal tumors therapeutics market is segmented as below:

By Distribution Channel

  • Hospital pharmacies
  • Retail pharmacies
  • Online pharmacies

By Route Of Administration

  • Oral
  • Parenteral

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the advent of regenerative therapy for gist as one of the prime reasons driving the gastrointestinal stromal tumors therapeutics market growth during the next few years. Also, strong pipeline for gist therapeutics and increasing research funding for gist therapeutics will lead to sizable demand in the market.

The report on the gastrointestinal stromal tumors therapeutics market covers the following areas:

  • Gastrointestinal stromal tumors therapeutics market sizing
  • Gastrointestinal stromal tumors therapeutics market forecast
  • Gastrointestinal stromal tumors therapeutics market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading gastrointestinal stromal tumors therapeutics market vendors that include Ascentage Pharma, Bayer AG, Blueprint Medicines Corp., Bristol Myers Squibb Co., Deciphera Pharmaceuticals Inc, Mendus AB, Novartis AG, Pfizer Inc., Sun Pharmaceutical Industries Ltd., Xencor Inc., AB Science SA, AROG Pharmaceuticals INC., Ipsen Pharma, Theseus Pharmaceuticals., Daiichi Sankyo Co. Ltd., Merck KGaA, and Takeda Pharmaceutical Co. Ltd.. Also, the gastrointestinal stromal tumors therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 06: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global gastrointestinal stromal tumors therapeutics market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global gastrointestinal stromal tumors therapeutics market 2018 - 2022 ($ billion)
4.2 Distribution Channel Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ billion)
4.3 Route of Administration Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Route of Administration Segment 2018 - 2022 ($ billion)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Distribution Channel
6.1 Market segments
Exhibit 30: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibit 31: Data Table on Distribution Channel - Market share 2023-2028 (%)
6.2 Comparison by Distribution Channel
Exhibit 32: Chart on Comparison by Distribution Channel
Exhibit 33: Data Table on Comparison by Distribution Channel
6.3 Hospital pharmacies - Market size and forecast 2023-2028
Exhibit 34: Chart on Hospital pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibit 35: Data Table on Hospital pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibit 36: Chart on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
6.4 Retail pharmacies - Market size and forecast 2023-2028
Exhibit 38: Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibit 39: Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibit 40: Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%)
6.5 Online pharmacies - Market size and forecast 2023-2028
Exhibit 42: Chart on Online pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibit 43: Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibit 44: Chart on Online pharmacies - Year-over-year growth 2023-2028 (%)
Exhibit 45: Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by Distribution Channel
Exhibit 46: Market opportunity by Distribution Channel ($ billion)
Exhibit 47: Data Table on Market opportunity by Distribution Channel ($ billion)
7 Market Segmentation by Route of Administration
7.1 Market segments
Exhibit 48: Chart on Route of Administration - Market share 2023-2028 (%)
Exhibit 49: Data Table on Route of Administration - Market share 2023-2028 (%)
7.2 Comparison by Route of Administration
Exhibit 50: Chart on Comparison by Route of Administration
Exhibit 51: Data Table on Comparison by Route of Administration
7.3 Oral - Market size and forecast 2023-2028
Exhibit 52: Chart on Oral - Market size and forecast 2023-2028 ($ billion)
Exhibit 53: Data Table on Oral - Market size and forecast 2023-2028 ($ billion)
Exhibit 54: Chart on Oral - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Oral - Year-over-year growth 2023-2028 (%)
7.4 Parenteral - Market size and forecast 2023-2028
Exhibit 56: Chart on Parenteral - Market size and forecast 2023-2028 ($ billion)
Exhibit 57: Data Table on Parenteral - Market size and forecast 2023-2028 ($ billion)
Exhibit 58: Chart on Parenteral - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Parenteral - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by Route of Administration
Exhibit 60: Market opportunity by Route of Administration ($ billion)
Exhibit 61: Data Table on Market opportunity by Route of Administration ($ billion)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 65: Chart on Geographic comparison
Exhibit 66: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 UK - Market size and forecast 2023-2028
Exhibit 87: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 88: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 89: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.9 China - Market size and forecast 2023-2028
Exhibit 91: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 92: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 93: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on China - Year-over-year growth 2023-2028 (%)
9.10 France - Market size and forecast 2023-2028
Exhibit 95: Chart on France - Market size and forecast 2023-2028 ($ billion)
Exhibit 96: Data Table on France - Market size and forecast 2023-2028 ($ billion)
Exhibit 97: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on France - Year-over-year growth 2023-2028 (%)
9.11 Japan - Market size and forecast 2023-2028
Exhibit 99: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibit 100: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibit 101: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 103: Market opportunity By Geographical Landscape ($ billion)
Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ billion)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 105: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 107: Overview on factors of disruption
11.4 Industry risks
Exhibit 108: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 109: Vendors covered
12.2 Market positioning of vendors
Exhibit 110: Matrix on vendor position and classification
12.3 AB Science SA
Exhibit 111: AB Science SA - Overview
Exhibit 112: AB Science SA - Product / Service
Exhibit 113: AB Science SA - Key offerings
12.4 AROG Pharmaceuticals INC.
Exhibit 114: AROG Pharmaceuticals INC. - Overview
Exhibit 115: AROG Pharmaceuticals INC. - Product / Service
Exhibit 116: AROG Pharmaceuticals INC. - Key offerings
12.5 Ascentage Pharma
Exhibit 117: Ascentage Pharma - Overview
Exhibit 118: Ascentage Pharma - Product / Service
Exhibit 119: Ascentage Pharma - Key offerings
12.6 Bayer AG
Exhibit 120: Bayer AG - Overview
Exhibit 121: Bayer AG - Business segments
Exhibit 122: Bayer AG - Key news
Exhibit 123: Bayer AG - Key offerings
Exhibit 124: Bayer AG - Segment focus
12.7 Blueprint Medicines Corp.
Exhibit 125: Blueprint Medicines Corp. - Overview
Exhibit 126: Blueprint Medicines Corp. - Product / Service
Exhibit 127: Blueprint Medicines Corp. - Key news
Exhibit 128: Blueprint Medicines Corp. - Key offerings
12.8 Bristol Myers Squibb Co.
Exhibit 129: Bristol Myers Squibb Co. - Overview
Exhibit 130: Bristol Myers Squibb Co. - Product / Service
Exhibit 131: Bristol Myers Squibb Co. - Key news
Exhibit 132: Bristol Myers Squibb Co. - Key offerings
12.9 Daiichi Sankyo Co. Ltd.
Exhibit 133: Daiichi Sankyo Co. Ltd. - Overview
Exhibit 134: Daiichi Sankyo Co. Ltd. - Product / Service
Exhibit 135: Daiichi Sankyo Co. Ltd. - Key news
Exhibit 136: Daiichi Sankyo Co. Ltd. - Key offerings
12.10 Deciphera Pharmaceuticals Inc
Exhibit 137: Deciphera Pharmaceuticals Inc - Overview
Exhibit 138: Deciphera Pharmaceuticals Inc - Business segments
Exhibit 139: Deciphera Pharmaceuticals Inc - Key news
Exhibit 140: Deciphera Pharmaceuticals Inc - Key offerings
Exhibit 141: Deciphera Pharmaceuticals Inc - Segment focus
12.11 Ipsen Pharma
Exhibit 142: Ipsen Pharma - Overview
Exhibit 143: Ipsen Pharma - Business segments
Exhibit 144: Ipsen Pharma - Key offerings
Exhibit 145: Ipsen Pharma - Segment focus
12.12 Mendus AB
Exhibit 146: Mendus AB - Overview
Exhibit 147: Mendus AB - Product / Service
Exhibit 148: Mendus AB - Key offerings
12.13 Novartis AG
Exhibit 149: Novartis AG - Overview
Exhibit 150: Novartis AG - Business segments
Exhibit 151: Novartis AG - Key offerings
Exhibit 152: Novartis AG - Segment focus
12.14 Pfizer Inc.
Exhibit 153: Pfizer Inc. - Overview
Exhibit 154: Pfizer Inc. - Product / Service
Exhibit 155: Pfizer Inc. - Key news
Exhibit 156: Pfizer Inc. - Key offerings
12.15 Sun Pharmaceutical Industries Ltd.
Exhibit 157: Sun Pharmaceutical Industries Ltd. - Overview
Exhibit 158: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibit 159: Sun Pharmaceutical Industries Ltd. - Key offerings
12.16 Theseus Pharmaceuticals.
Exhibit 160: Theseus Pharmaceuticals. - Overview
Exhibit 161: Theseus Pharmaceuticals. - Product / Service
Exhibit 162: Theseus Pharmaceuticals. - Key offerings
12.17 Xencor Inc.
Exhibit 163: Xencor Inc. - Overview
Exhibit 164: Xencor Inc. - Product / Service
Exhibit 165: Xencor Inc. - Key news
Exhibit 166: Xencor Inc. - Key offerings
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 167: Inclusions checklist
Exhibit 168: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 169: Currency conversion rates for US$
13.4 Research methodology
Exhibit 170: Research methodology
Exhibit 171: Validation techniques employed for market sizing
Exhibit 172: Information sources
13.5 List of abbreviations
Exhibit 173: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits 6: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 18: Historic Market Size - Data Table on global gastrointestinal stromal tumors therapeutics market 2018 - 2022 ($ billion)
Exhibits 19: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ billion)
Exhibits 20: Historic Market Size - Route of Administration Segment 2018 - 2022 ($ billion)
Exhibits 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibits 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibits 23: Five forces analysis - Comparison between 2023 and 2028
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 29: Chart on Market condition - Five forces 2023 and 2028
Exhibits 30: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibits 31: Data Table on Distribution Channel - Market share 2023-2028 (%)
Exhibits 32: Chart on Comparison by Distribution Channel
Exhibits 33: Data Table on Comparison by Distribution Channel
Exhibits 34: Chart on Hospital pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibits 35: Data Table on Hospital pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibits 36: Chart on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits 37: Data Table on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits 38: Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibits 39: Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibits 40: Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits 41: Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits 42: Chart on Online pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibits 43: Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibits 44: Chart on Online pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits 45: Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits 46: Market opportunity by Distribution Channel ($ billion)
Exhibits 47: Data Table on Market opportunity by Distribution Channel ($ billion)
Exhibits 48: Chart on Route of Administration - Market share 2023-2028 (%)
Exhibits 49: Data Table on Route of Administration - Market share 2023-2028 (%)
Exhibits 50: Chart on Comparison by Route of Administration
Exhibits 51: Data Table on Comparison by Route of Administration
Exhibits 52: Chart on Oral - Market size and forecast 2023-2028 ($ billion)
Exhibits 53: Data Table on Oral - Market size and forecast 2023-2028 ($ billion)
Exhibits 54: Chart on Oral - Year-over-year growth 2023-2028 (%)
Exhibits 55: Data Table on Oral - Year-over-year growth 2023-2028 (%)
Exhibits 56: Chart on Parenteral - Market size and forecast 2023-2028 ($ billion)
Exhibits 57: Data Table on Parenteral - Market size and forecast 2023-2028 ($ billion)
Exhibits 58: Chart on Parenteral - Year-over-year growth 2023-2028 (%)
Exhibits 59: Data Table on Parenteral - Year-over-year growth 2023-2028 (%)
Exhibits 60: Market opportunity by Route of Administration ($ billion)
Exhibits 61: Data Table on Market opportunity by Route of Administration ($ billion)
Exhibits 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 65: Chart on Geographic comparison
Exhibits 66: Data Table on Geographic comparison
Exhibits 67: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits 68: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits 69: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 71: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits 72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 75: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits 76: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 83: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits 84: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits 85: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 86: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 87: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits 88: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits 89: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits 90: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits 91: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibits 92: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibits 93: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits 94: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits 95: Chart on France - Market size and forecast 2023-2028 ($ billion)
Exhibits 96: Data Table on France - Market size and forecast 2023-2028 ($ billion)
Exhibits 97: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibits 98: Data Table on France - Year-over-year growth 2023-2028 (%)
Exhibits 99: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibits 100: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibits 101: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 102: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 103: Market opportunity By Geographical Landscape ($ billion)
Exhibits 104: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits 105: Impact of drivers and challenges in 2023 and 2028
Exhibits 106: Overview on Criticality of inputs and Factors of differentiation
Exhibits 107: Overview on factors of disruption
Exhibits 108: Impact of key risks on business
Exhibits 109: Vendors covered
Exhibits 110: Matrix on vendor position and classification
Exhibits 111: AB Science SA - Overview
Exhibits 112: AB Science SA - Product / Service
Exhibits 113: AB Science SA - Key offerings
Exhibits 114: AROG Pharmaceuticals INC. - Overview
Exhibits 115: AROG Pharmaceuticals INC. - Product / Service
Exhibits 116: AROG Pharmaceuticals INC. - Key offerings
Exhibits 117: Ascentage Pharma - Overview
Exhibits 118: Ascentage Pharma - Product / Service
Exhibits 119: Ascentage Pharma - Key offerings
Exhibits 120: Bayer AG - Overview
Exhibits 121: Bayer AG - Business segments
Exhibits 122: Bayer AG - Key news
Exhibits 123: Bayer AG - Key offerings
Exhibits 124: Bayer AG - Segment focus
Exhibits 125: Blueprint Medicines Corp. - Overview
Exhibits 126: Blueprint Medicines Corp. - Product / Service
Exhibits 127: Blueprint Medicines Corp. - Key news
Exhibits 128: Blueprint Medicines Corp. - Key offerings
Exhibits 129: Bristol Myers Squibb Co. - Overview
Exhibits 130: Bristol Myers Squibb Co. - Product / Service
Exhibits 131: Bristol Myers Squibb Co. - Key news
Exhibits 132: Bristol Myers Squibb Co. - Key offerings
Exhibits 133: Daiichi Sankyo Co. Ltd. - Overview
Exhibits 134: Daiichi Sankyo Co. Ltd. - Product / Service
Exhibits 135: Daiichi Sankyo Co. Ltd. - Key news
Exhibits 136: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibits 137: Deciphera Pharmaceuticals Inc - Overview
Exhibits 138: Deciphera Pharmaceuticals Inc - Business segments
Exhibits 139: Deciphera Pharmaceuticals Inc - Key news
Exhibits 140: Deciphera Pharmaceuticals Inc - Key offerings
Exhibits 141: Deciphera Pharmaceuticals Inc - Segment focus
Exhibits 142: Ipsen Pharma - Overview
Exhibits 143: Ipsen Pharma - Business segments
Exhibits 144: Ipsen Pharma - Key offerings
Exhibits 145: Ipsen Pharma - Segment focus
Exhibits 146: Mendus AB - Overview
Exhibits 147: Mendus AB - Product / Service
Exhibits 148: Mendus AB - Key offerings
Exhibits 149: Novartis AG - Overview
Exhibits 150: Novartis AG - Business segments
Exhibits 151: Novartis AG - Key offerings
Exhibits 152: Novartis AG - Segment focus
Exhibits 153: Pfizer Inc. - Overview
Exhibits 154: Pfizer Inc. - Product / Service
Exhibits 155: Pfizer Inc. - Key news
Exhibits 156: Pfizer Inc. - Key offerings
Exhibits 157: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits 158: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibits 159: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits 160: Theseus Pharmaceuticals. - Overview
Exhibits 161: Theseus Pharmaceuticals. - Product / Service
Exhibits 162: Theseus Pharmaceuticals. - Key offerings
Exhibits 163: Xencor Inc. - Overview
Exhibits 164: Xencor Inc. - Product / Service
Exhibits 165: Xencor Inc. - Key news
Exhibits 166: Xencor Inc. - Key offerings
Exhibits 167: Inclusions checklist
Exhibits 168: Exclusions checklist
Exhibits 169: Currency conversion rates for US$
Exhibits 170: Research methodology
Exhibits 171: Validation techniques employed for market sizing
Exhibits 172: Information sources
Exhibits 173: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global gastrointestinal stromal tumors therapeutics market: Ascentage Pharma, Bayer AG, Blueprint Medicines Corp., Bristol Myers Squibb Co., Deciphera Pharmaceuticals Inc, Mendus AB, Novartis AG, Pfizer Inc., Sun Pharmaceutical Industries Ltd., Xencor Inc., AB Science SA, AROG Pharmaceuticals INC., Ipsen Pharma, Theseus Pharmaceuticals., Daiichi Sankyo Co. Ltd., Merck KGaA, and Takeda Pharmaceutical Co. Ltd..

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is the advent of regenerative therapy for gist.'

According to the report, one of the major drivers for this market is the growing geriatric population.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Ascentage Pharma
  • Bayer AG
  • Blueprint Medicines Corp.
  • Bristol Myers Squibb Co.
  • Deciphera Pharmaceuticals Inc
  • Mendus AB
  • Novartis AG
  • Pfizer Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Xencor Inc.
  • AB Science SA
  • AROG Pharmaceuticals INC.
  • Ipsen Pharma
  • Theseus Pharmaceuticals.
  • Daiichi Sankyo Co. Ltd.
  • Merck KGaA
  • Takeda Pharmaceutical Co. Ltd.

Related Topics

Related Reports

Gastrointestinal Stromal Tumors Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

Gastrointestinal Stromal Tumors Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 107 Pages
  • Global
From
Gastrointestinal Stromal Tumor Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region - Product Image

Gastrointestinal Stromal Tumor Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region

  • Report
  • 170 Pages
  • Global
Global CTLA4 (Cytotoxic T-Lymphocyte-Associated Protein 4) Inhibitors Market 2024-2028 - Product Image

Global CTLA4 (Cytotoxic T-Lymphocyte-Associated Protein 4) Inhibitors Market 2024-2028

  • Report
  • 163 Pages
  • Global
From
Global Proteasome Inhibitors Market 2024-2028 - Product Image

Global Proteasome Inhibitors Market 2024-2028

  • Report
  • 173 Pages
  • Global
From
Gastrointestinal Stromal Tumor Global Market Report 2024 - Product Image

Gastrointestinal Stromal Tumor Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.